Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Jiaan Sun, Ruijie Xie, Yongfeng Yin, Lanjuan Xu
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Asymptomatic hyperuricaemia: a silent activator of the innate immune system.
10.1038/s41584-019-0334-3 · 2020
Uric acid and the development of metabolic syndrome in women and men.
10.1016/j.metabol.2008.01.030 · 2008
Worldwide trends in hyperuricaemia from 2000 to 2023: a systematic review and modelling analysis.
10.1016/s2665-9913(25)00344-3 · 2026
Hyperuricemia and its related diseases: mechanisms and advances in therapy.
10.1038/s41392-024-01916-y · 2024
Hyperuricemia and incident hypertension: a systematic review and meta-analysis.
10.1002/acr.20344 · 2011
Serum uric acid and risk of incident chronic kidney disease: a national cohort study and updated meta-analysis.
10.1186/s12986-021-00618-4 · 2021
Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis.
10.2147/clep.s403314 · 2023
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
10.1016/j.ejim.2020.07.006 · 2020
Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study.
10.1016/j.jacc.2015.10.086 · 2016
No causal effects of serum urate levels on the risk of chronic kidney disease: a Mendelian randomization study.
10.1371/journal.pmed.1002725 · 2019
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
10.1093/eurheartj/ehz455 · 2020
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999-2018.
10.1186/s12916-024-03536-3 · 2024
Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.
10.1016/j.ijcard.2013.03.027 · 2013
High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
10.1161/atvbaha.112.300133 · 2012
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.
10.1002/emmm.201200224 · 2012
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of coronary artery disease.
10.1155/2020/7146028 · 2020
Non-high-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort study.
10.1111/1753-0407.12650 · 2018
The Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) to HDL-C Ratio (NHHR) and its association with chronic kidney disease in chinese adults with type 2 diabetes: a preliminary study.
10.3390/nu17071125 · 2025
Association between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio (NHHR) and Stroke among Adults in the USA: a cross-sectional NHANES Study.
2025
Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).
10.1093/ije/dys203 · 2014
The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia.
10.1186/s12944-024-02171-4 · 2024
Unresolved referenced work
2000
Nonlinear association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hyperuricemia in cancer patients: evidence from NHANES 2007-2018.
10.1186/s12944-024-02261-3 · 2024
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease in patients with diabetes in the United States: a cross-sectional study.
10.1186/s12944-024-02308-5 · 2024
Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey.
10.1002/art.20821 · 2004
Purine-rich foods, dairy and protein intake, and the risk of gout in men.
10.1056/nejmoa035700 · 2004
Fructose-rich beverages and risk of gout in women.
10.1001/jama.2010.1638 · 2010
Metabolic syndrome, diabetes, and hyperuricemia.
10.1097/bor.0b013e32835d951e · 2013
HDL and reverse cholesterol transport.
10.1161/circresaha.119.312617 · 2019
HDL and reverse cholesterol transport.
10.1161/circresaha.119.312617 · doi-reference
Metabolic syndrome, diabetes, and hyperuricemia.
10.1097/bor.0b013e32835d951e · doi-reference
Fructose-rich beverages and risk of gout in women.
10.1001/jama.2010.1638 · doi-reference
Purine-rich foods, dairy and protein intake, and the risk of gout in men.
10.1056/nejmoa035700 · doi-reference
Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey.
10.1002/art.20821 · doi-reference
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease in patients with diabetes in the United States: a cross-sectional study.
10.1186/s12944-024-02308-5 · doi-reference
Nonlinear association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hyperuricemia in cancer patients: evidence from NHANES 2007-2018.
10.1186/s12944-024-02261-3 · doi-reference
The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia.
10.1186/s12944-024-02171-4 · doi-reference
Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).
10.1093/ije/dys203 · doi-reference
The Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) to HDL-C Ratio (NHHR) and its association with chronic kidney disease in chinese adults with type 2 diabetes: a preliminary study.
10.3390/nu17071125 · doi-reference
Non-high-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort study.
10.1111/1753-0407.12650 · doi-reference
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of coronary artery disease.
10.1155/2020/7146028 · doi-reference
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.
10.1002/emmm.201200224 · doi-reference
High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
10.1161/atvbaha.112.300133 · doi-reference
Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.
10.1016/j.ijcard.2013.03.027 · doi-reference
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999-2018.
10.1186/s12916-024-03536-3 · doi-reference
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
10.1093/eurheartj/ehz455 · doi-reference
No causal effects of serum urate levels on the risk of chronic kidney disease: a Mendelian randomization study.
10.1371/journal.pmed.1002725 · doi-reference
Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study.
10.1016/j.jacc.2015.10.086 · doi-reference
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
10.1016/j.ejim.2020.07.006 · doi-reference
Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis.
10.2147/clep.s403314 · doi-reference
Serum uric acid and risk of incident chronic kidney disease: a national cohort study and updated meta-analysis.
10.1186/s12986-021-00618-4 · doi-reference
Hyperuricemia and incident hypertension: a systematic review and meta-analysis.
10.1002/acr.20344 · doi-reference
Hyperuricemia and its related diseases: mechanisms and advances in therapy.
10.1038/s41392-024-01916-y · doi-reference
Worldwide trends in hyperuricaemia from 2000 to 2023: a systematic review and modelling analysis.
10.1016/s2665-9913(25)00344-3 · doi-reference
Uric acid and the development of metabolic syndrome in women and men.
10.1016/j.metabol.2008.01.030 · doi-reference
Asymptomatic hyperuricaemia: a silent activator of the innate immune system.
10.1038/s41584-019-0334-3 · doi-reference